SCHIATTARELLA, GABRIELE GIACOMO
 Distribuzione geografica
Continente #
NA - Nord America 931
EU - Europa 622
AS - Asia 442
AF - Africa 22
OC - Oceania 2
SA - Sud America 1
Totale 2.020
Nazione #
US - Stati Uniti d'America 910
IT - Italia 352
SG - Singapore 219
CN - Cina 165
NL - Olanda 81
DE - Germania 40
IE - Irlanda 35
FI - Finlandia 30
VN - Vietnam 28
GB - Regno Unito 26
CI - Costa d'Avorio 22
CA - Canada 21
FR - Francia 21
SE - Svezia 17
IN - India 9
TR - Turchia 9
BE - Belgio 4
ES - Italia 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
ID - Indonesia 3
RS - Serbia 3
JP - Giappone 2
TH - Thailandia 2
AT - Austria 1
AU - Australia 1
BR - Brasile 1
HK - Hong Kong 1
IR - Iran 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SA - Arabia Saudita 1
UA - Ucraina 1
Totale 2.020
Città #
Singapore 170
Chandler 169
Ashburn 82
Amsterdam 77
Napoli 63
Beijing 46
Millbury 45
Naples 38
Princeton 38
Nanjing 30
Des Moines 29
Boston 28
Dong Ket 28
Santa Clara 26
Ottawa 18
Lawrence 12
Wilmington 12
Rome 11
Nanchang 10
Redwood City 10
Tianjin 10
Fairfield 8
Hebei 8
Washington 8
Shenyang 7
Augusta 6
Jiaxing 6
Turin 6
Borghetto Santo Spirito 5
Ankara 4
Caserta 4
Cervia 4
Jacksonville 4
Kunming 4
Köln 4
Norwalk 4
Salerno 4
Stella Cilento 4
Belgrade 3
Berlin 3
Brno 3
Changsha 3
Jakarta 3
Kronberg 3
Los Angeles 3
Marsala 3
Nocera Superiore 3
Nürnberg 3
Piedimonte 3
Shanghai 3
The Dalles 3
Tokat Province 3
Vertova 3
Bacoli 2
Bari 2
Bern 2
Brussels 2
Cabiate 2
Casalnuovo Di Napoli 2
Dearborn 2
Florence 2
Giugliano In Campania 2
Hangzhou 2
Indiana 2
Kolkata 2
Leggiuno 2
Massy 2
New York 2
Paterno 2
Paullo 2
Pune 2
Richmond 2
Seattle 2
Sunnyvale 2
Tokyo 2
Villaricca 2
Ann Arbor 1
Ardabil 1
Avellino 1
Bagheria 1
Baranzate 1
Barcelona 1
Battipaglia 1
Boardman 1
Casandrino 1
Castellabate 1
Castelnuovo Di Porto 1
Catanzaro 1
Central 1
Chengdu 1
Clifton 1
Como 1
Dallas 1
Edinburgh 1
Fisciano 1
Fort Collins 1
Fremont 1
Geneve 1
Genova 1
Guangzhou 1
Totale 1.157
Nome #
Akap1 deficiency promotes mitochondrial aberrations and exacerbates cardiac injury following permanent coronary ligation via enhanced mitophagy and apoptosis 81
Akap1 Regulates Vascular Function and Endothelial Cells Behavior 80
Correction: Akap1 deficiency promotes mitochondrial aberrations and exacerbates cardiac injury following permanent coronary ligation via enhanced mitophagy and apoptosis 72
EGFR activation triggers cellular hypertrophy and lysosomal disease in NAGLU-depleted cardiomyoblasts, mimicking the hallmarks of mucopolysaccharidosis IIIB 70
AKAP121 downregulation impairs protective cAMP signals, promotes mitochondrial dysfunction, and increases oxidative stress. 64
Epigenetic Switch at Atp2a2 and Myh7 Gene Promoters in Pressure Overload-Induced Heart Failure 61
Dermcidin: a skeletal muscle myokine modulating cardiomyocyte survival and infarct size after coronary artery ligation 58
Meta-Analysis of Mortality Outcomes and Mitral Regurgitation Evolution in 4,839 Patients Having Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis. 56
A meta-analysis of the impact of pre-existing and new-onset atrial fibrillation on clinical outcomes in patients undergoing transcatheter aortic valve implantation 56
Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis 56
Loss of Akap1 exacerbates pressure overload-induced cardiac hypertrophy and heart failure 56
The Murine Model of Mucopolysaccharidosis IIIB Develops Cardiopathies over Time Leading to Heart Failure 55
IDENTIFICAZIONE PROTEOMICA DI UN NUOVO FATTORE COINVOLTO NELLA MODULAZIONE MOLECOLARE DEL RIMODELLAMENTO CARDIACO POST-ISCHEMICO NELL'ISCHEMIA CRONICA DEGLI ARTI INFERIORI. 48
Prevalence and characteristics of true and apparent treatment resistant hypertension in the Campania Salute Network. 48
Transverse aortic constriction induces gut barrier alterations, microbiota remodeling and systemic inflammation [*Boccella N., Paolillo R. and Coretti L. co-first authors] 47
ATHERECTOMY AS ALTERNATIVE ENDOVASCULAR THERAPY FOR INFRAINGUINAL ARTERY DISEASE. 46
Impact of chronic kidney disease on platelet aggregation in patients with acute coronary syndrome 42
Cardiovascular effects of histone deacetylase inhibitors epigenetic therapies: Systematic review of 62 studies and new hypotheses for future research 42
Moderate to severe mitral regurgitation in patients undergoing trancatheter aortic valve replacement: a meta-analysis of mortality outcomes and mitral regurgitation evolution in 4,933 patients 41
Effects of Carvedilol Versus Metoprolol on Platelet Aggregation in Patients With Acute Coronary Syndrome: The PLATE-BLOCK Study 40
Effects of a New Combination of Nutraceuticals with Morus alba on Lipid Profile, Insulin Sensitivity and Endotelial Function in Dyslipidemic Subjects. A Cross-Over, Randomized, Double-Blind Trial. 39
Rac-1 as a new target to modulate endothelial function and platelet aggregation in diabetes mellitus 39
The role of mitochondrial dynamics in cardiovascular diseases 39
Cardiac Side Effects of Chemotherapy: State of Art and Strategies for a Correct Management. 37
Diagnostics and therapeutic implications of gut microbiota alterations in cardiometabolic diseases 37
Immunoglobulins G modulate endothelial function and affect insulin sensitivity in humans 36
Novel Molecular Approaches in Heart Failure: Seven Trans-Membrane Receptors Signaling in the Heart and Circulating Blood Leukocytes 35
Survival and Cardiovascular Outcomes of Patients With Secondary Mitral Regurgitation: A Systematic Review and Meta-analysis 32
Use of statins in lower extremity artery disease: a review 31
Statins and the elderly: Recent evidence and current indications 31
Increased mortality after transcatheter aortic valve implantation (TAVI) in patients with severe aortic stenosis and low ejection fraction: A meta-analysis of 6898 patients 31
Distinctive patterns of inflammation across the heart failure syndrome 31
Meta-Analysis of Effect of Body Mass Index on Outcomes After Transcatheter Aortic Valve Implantation 30
A collagen membrane-based engineered heart tissue improves cardiac function in ischemic rat hearts 30
Comparison of Baseline Characteristics and Outcomes in Men Versus Women With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation 30
AngioJet rheolytic thrombectomy for acute superficial femoral artery stent or femoropopliteal by-pass thrombosis 29
SAFETY AND EFFICACY OF OUBACK CATHETER-ASSISTED SUBINTIMAL RECANALIZATION OF TOTAL CHRONIC ILIAC ARTERY OCCLUSION. 28
Feeding Diastolic Dysfunction: Is It a Bug? 28
RUOLO PROTETTIVO DELL'UNCOUPLING PROTEIN 3 (UCP3) NELLA MALATTIA ISCHEMICA. 27
MIR-21 ANTAGONISM IMPROVES LEFT VENTRICULAR REMODELLING AND FUNCTION AFTER MYOCARDIAL INFARCTION IN MICE. 27
Cardiac metabolism in HFpEF: from fuel to signalling 26
Induction of mitogen-activated protein kinases is proportional to the amount of pressure overload. 26
Nuovi concetti nella segnalazione beta-adrenergica: prospettive terapeutiche per lo scompenso cardiaco.. [Novel concepts in beta-adrenergic receptor signaling: therapeutic options for heart failure]. 24
Pre-existing and new-onset atrial fibrillation: a meta-analysis of mortality outcomes and cerebrovascular events in 13,795 patients undergoing transcatheter aortic valve implantation 23
Immunometabolic Mechanisms of Heart Failure with Preserved Ejection Fraction 23
Mitochondrial a Kinase Anchor Proteins in Cardiovascular Health and Disease: A Review Article on Behalf of the Working Group on Cellular and Molecular Biology of the Heart of the Italian Society of Cardiology 22
Novel basic science insights to improve the management of heart failure: Review of the working group on cellular and molecular biology of the heart of the italian society of cardiology 22
Can hfpef and hfref coexist? 21
Double layered stents for carotid angioplasty: A meta-analysis of available clinical data 20
Rac 1 modulates endothelial function and platelet aggregation in diabetes mellitus 18
Inflammation in aortic stenosis: Shaping the biomarkers network 18
Fibroblast Primary Cilia Are Required for Cardiac Fibrosis 18
Long COVID and the cardiovascular system - elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: A joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial & Pericardial Diseases 17
Therapeutic targeting of autophagy in cardiovascular disease 15
Xbp1s-FoxO1 axis governs lipid accumulation and contractile performance in heart failure with preserved ejection fraction 14
NAD+Repletion Reverses Heart Failure with Preserved Ejection Fraction 11
Heart failure with preserved ejection fraction in humans and mice: Embracing clinical complexity in mouse models 10
Metabolic inflammation in heart failure with preserved ejection fraction 10
A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function 9
Activation of Autophagic Flux Blunts Cardiac Ischemia/Reperfusion Injury 9
FoxO1–Dio2 signaling axis governs cardiomyocyte thyroid hormone metabolism and hypertrophic growth 9
Nitrosative stress drives heart failure with preserved ejection fraction 9
Tackling metabolic defects in HFpEF 8
Implications of SGLT Inhibition on Redox Signalling in Atrial Fibrillation 8
Epigenetic Reader BRD4 (Bromodomain-Containing Protein 4) Governs Nucleus-Encoded Mitochondrial Transcriptome to Regulate Cardiac Function 8
High-Resolution Transthoracic Echocardiography Accurately Detects Pulmonary Arterial Pressure and Decreased Right Ventricular Contractility in a Mouse Model of Pulmonary Fibrosis and Secondary Pulmonary Hypertension 7
Canagliflozin and myocardial oxidative stress: SGLT1 inhibition takes centre stage 6
Microbial metabolites as predictive biomarkers: A paradigm shift for cardiovascular risk stratification 6
Metabolism and Inflammation in Cardiovascular Health and Diseases: Mechanisms to Therapies 6
Cooperative Binding of ETS2 and NFAT Links Erk1/2 and Calcineurin Signaling in the Pathogenesis of Cardiac Hypertrophy 5
Impaired AMP-Activated Protein Kinase Signaling in Heart Failure With Preserved Ejection Fraction-Associated Atrial Fibrillation 5
Remodeling of substrate consumption in the murine sTAC model of heart failure 5
Polycystin-1 Assembles With Kv Channels to Govern Cardiomyocyte Repolarization and Contractility 5
Female Sex Is Protective in a Preclinical Model of Heart Failure with Preserved Ejection Fraction 4
Left ventricular dysfunction in heart failure with preserved ejection fraction—molecular mechanisms and impact on right ventricular function 3
Up next: The dawn of systems biology in HFpEF research 1
Metabolic control and oxidative stress in pathological cardiac remodelling 1
Totale 2.218
Categoria #
all - tutte 10.722
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.722


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020111 0 0 0 0 9 5 8 1 17 31 30 10
2020/2021183 5 3 14 5 9 17 11 9 51 2 22 35
2021/2022361 12 1 0 3 19 9 9 23 44 44 87 110
2022/2023475 53 22 13 23 52 55 27 52 61 92 20 5
2023/2024381 19 53 53 37 19 51 13 37 10 8 48 33
2024/2025306 97 111 9 62 27 0 0 0 0 0 0 0
Totale 2.218